AI Chronic Disease Management - Global and China Top Players Market Share and Ranking 2025- YH Research

Home > Reports >Medical Care > AI Chronic Disease Management - Global and China Top Players Market Share and Ranking 2025

AI Chronic Disease Management - Global and China Top Players Market Share and Ranking 2025

Publication Date: 2025-08-27
Report Id: 2367219
Industry: Medical Care
Report Page: 125
Chart: 121

PDF Download

Publication Date: 2025-08-27
Report Id: 2367219
Industry: Medical Care
Report Page: 125
Chart: 121

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 AI Chronic Disease Management Definition
1.2 Global AI Chronic Disease Management Market Size and Forecast
1.3 China AI Chronic Disease Management Market Size and Forecast
1.4 Share of China AI Chronic Disease Management Market with Respect to the Global Market
1.5 AI Chronic Disease Management Market Size: China VS Global Growth Rate, 2020-2031
1.6 AI Chronic Disease Management Market Dynamics
1.6.1 AI Chronic Disease Management Market Drivers
1.6.2 AI Chronic Disease Management Market Restraints
1.6.3 AI Chronic Disease Management Industry Trends
1.6.4 AI Chronic Disease Management Industry Policy

2 Global Leading Players and Market Share
2.1 By Revenue of AI Chronic Disease Management, Global Market Share by Company, 2020-2025
2.2 Global AI Chronic Disease Management Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global AI Chronic Disease Management Concentration Ratio
2.4 Global AI Chronic Disease Management Mergers & Acquisitions, Expansion Plans
2.5 Global AI Chronic Disease Management Major Companies Product Type
2.6 Head Office and Area Served of Key Players

3 China Leading Players, Market Share and Ranking
3.1 By Revenue of AI Chronic Disease Management, China Market Share by Company, 2020-2025
3.2 China AI Chronic Disease Management AI Chronic Disease Management Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis
4.1 AI Chronic Disease Management Industry Chain
4.2 AI Chronic Disease Management Upstream Analysis
4.2.1 AI Chronic Disease Management Core Raw Materials
4.2.2 Main Manufacturers of AI Chronic Disease Management Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 AI Chronic Disease Management Production Mode
4.6 AI Chronic Disease Management Procurement Model
4.7 AI Chronic Disease Management Industry Sales Model and Sales Channels
4.7.1 AI Chronic Disease Management Sales Model
4.7.2 AI Chronic Disease Management Typical Distributors

5 Sights by Type
5.1 AI Chronic Disease Management Classification by Type
5.1.1 Mobile Applications
5.1.2 Wearable Hardware
5.1.3 Cloud Platform
5.1.4 Others
5.2 by Type, Global AI Chronic Disease Management Consumption Value & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global AI Chronic Disease Management Consumption Value, 2020-2031

6 Sights by Application
6.1 AI Chronic Disease Management Segment by Application
6.1.1 Home
6.1.2 Commercial
6.1.3 Medical
6.1.4 Others
6.2 by Application, Global AI Chronic Disease Management Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global AI Chronic Disease Management Consumption Value, 2020-2031

7 Sales Sights by Region
7.1 By Region, Global AI Chronic Disease Management Consumption Value, 2020 VS 2024 VS 2031
7.2 By Region, Global AI Chronic Disease Management Consumption Value, 2020-2031
7.3 North America
7.3.1 North America AI Chronic Disease Management Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America AI Chronic Disease Management Market Size Market Share
7.4 Europe
7.4.1 Europe AI Chronic Disease Management Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe AI Chronic Disease Management Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific AI Chronic Disease Management Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific AI Chronic Disease Management Market Size Market Share
7.6 South America
7.6.1 South AmericaAI Chronic Disease Management Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America AI Chronic Disease Management Market Size Market Share
7.7 Middle East & Africa

8 Sales Sights by Country Level
8.1 By Country, Global AI Chronic Disease Management Market Size & CAGR, 2020 VS 2024 VS 2031
8.2 By Country, Global AI Chronic Disease Management Consumption Value, 2020-2031
8.3 United States
8.3.1 United States AI Chronic Disease Management Market Size, 2020-2031
8.3.2 by Type, United States AI Chronic Disease Management Consumption Value Market Share, 2024 VS 2031
8.3.3 by Application, United States AI Chronic Disease Management Consumption Value Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe AI Chronic Disease Management Market Size, 2020-2031
8.4.2 by Type, Europe AI Chronic Disease Management Consumption Value Market Share, 2024 VS 2031
8.4.3 by Application, Europe AI Chronic Disease Management Consumption Value Market Share, 2024 VS 2031
8.5 China
8.5.1 China AI Chronic Disease Management Market Size, 2020-2031
8.5.2 by Type, China AI Chronic Disease Management Consumption Value Market Share, 2024 VS 2031
8.5.3 by Application, China AI Chronic Disease Management Consumption Value Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan AI Chronic Disease Management Market Size, 2020-2031
8.6.2 by Type, Japan AI Chronic Disease Management Consumption Value Market Share, 2024 VS 2031
8.6.3 by Application, Japan AI Chronic Disease Management Consumption Value Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea AI Chronic Disease Management Market Size, 2020-2031
8.7.2 by Type, South Korea AI Chronic Disease Management Consumption Value Market Share, 2024 VS 2031
8.7.3 by Application, South Korea AI Chronic Disease Management Consumption Value Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia AI Chronic Disease Management Market Size, 2020-2031
8.8.2 by Type, Southeast Asia AI Chronic Disease Management Consumption Value Market Share, 2024 VS 2031
8.8.3 by Application, Southeast Asia AI Chronic Disease Management Consumption Value Market Share, 2024 VS 2031
8.9 India
8.9.1 India AI Chronic Disease Management Market Size, 2020-2031
8.9.2 by Type, India AI Chronic Disease Management Consumption Value Market Share, 2024 VS 2031
8.9.3 by Application, India AI Chronic Disease Management Consumption Value Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa AI Chronic Disease Management Market Size, 2020-2031
8.10.2 by Type, Middle East & Africa AI Chronic Disease Management Consumption Value Market Share, 2024 VS 2031
8.10.3 by Application, Middle East & Africa AI Chronic Disease Management Consumption Value Market Share, 2024 VS 2031

9 Company Profile
9.1 Teladoc Health
9.1.1 Teladoc Health Company Information, Head Office, Market Area, and Industry Position
9.1.2 Teladoc Health Company Profile and Main Business
9.1.3 Teladoc Health AI Chronic Disease Management Models, Specifications, and Application
9.1.4 Teladoc Health AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.1.5 Teladoc Health Recent Developments
9.2 S3 Connected Health
9.2.1 S3 Connected Health Company Information, Head Office, Market Area, and Industry Position
9.2.2 S3 Connected Health Company Profile and Main Business
9.2.3 S3 Connected Health AI Chronic Disease Management Models, Specifications, and Application
9.2.4 S3 Connected Health AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.2.5 S3 Connected Health Recent Developments
9.3 Cognizant
9.3.1 Cognizant Company Information, Head Office, Market Area, and Industry Position
9.3.2 Cognizant Company Profile and Main Business
9.3.3 Cognizant AI Chronic Disease Management Models, Specifications, and Application
9.3.4 Cognizant AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.3.5 Cognizant Recent Developments
9.4 Omada Health
9.4.1 Omada Health Company Information, Head Office, Market Area, and Industry Position
9.4.2 Omada Health Company Profile and Main Business
9.4.3 Omada Health AI Chronic Disease Management Models, Specifications, and Application
9.4.4 Omada Health AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.4.5 Omada Health Recent Developments
9.5 WellDoc
9.5.1 WellDoc Company Information, Head Office, Market Area, and Industry Position
9.5.2 WellDoc Company Profile and Main Business
9.5.3 WellDoc AI Chronic Disease Management Models, Specifications, and Application
9.5.4 WellDoc AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.5.5 WellDoc Recent Developments
9.6 Epic Systems
9.6.1 Epic Systems Company Information, Head Office, Market Area, and Industry Position
9.6.2 Epic Systems Company Profile and Main Business
9.6.3 Epic Systems AI Chronic Disease Management Models, Specifications, and Application
9.6.4 Epic Systems AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.6.5 Epic Systems Recent Developments
9.7 Pathmate
9.7.1 Pathmate Company Information, Head Office, Market Area, and Industry Position
9.7.2 Pathmate Company Profile and Main Business
9.7.3 Pathmate AI Chronic Disease Management Models, Specifications, and Application
9.7.4 Pathmate AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.7.5 Pathmate Recent Developments
9.8 EveryDose
9.8.1 EveryDose Company Information, Head Office, Market Area, and Industry Position
9.8.2 EveryDose Company Profile and Main Business
9.8.3 EveryDose AI Chronic Disease Management Models, Specifications, and Application
9.8.4 EveryDose AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.8.5 EveryDose Recent Developments
9.9 Aptar Digital Health
9.9.1 Aptar Digital Health Company Information, Head Office, Market Area, and Industry Position
9.9.2 Aptar Digital Health Company Profile and Main Business
9.9.3 Aptar Digital Health AI Chronic Disease Management Models, Specifications, and Application
9.9.4 Aptar Digital Health AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.9.5 Aptar Digital Health Recent Developments
9.10 VITech
9.10.1 VITech Company Information, Head Office, Market Area, and Industry Position
9.10.2 VITech Company Profile and Main Business
9.10.3 VITech AI Chronic Disease Management Models, Specifications, and Application
9.10.4 VITech AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.10.5 VITech Recent Developments
9.11 Virta Health
9.11.1 Virta Health Company Information, Head Office, Market Area, and Industry Position
9.11.2 Virta Health Company Profile and Main Business
9.11.3 Virta Health AI Chronic Disease Management Models, Specifications, and Application
9.11.4 Virta Health AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.11.5 Virta Health Recent Developments
9.12 Glooko
9.12.1 Glooko Company Information, Head Office, Market Area, and Industry Position
9.12.2 Glooko Company Profile and Main Business
9.12.3 Glooko AI Chronic Disease Management Models, Specifications, and Application
9.12.4 Glooko AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.12.5 Glooko Recent Developments
9.13 Dexcom
9.13.1 Dexcom Company Information, Head Office, Market Area, and Industry Position
9.13.2 Dexcom Company Profile and Main Business
9.13.3 Dexcom AI Chronic Disease Management Models, Specifications, and Application
9.13.4 Dexcom AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.13.5 Dexcom Recent Developments
9.14 Philips
9.14.1 Philips Company Information, Head Office, Market Area, and Industry Position
9.14.2 Philips Company Profile and Main Business
9.14.3 Philips AI Chronic Disease Management Models, Specifications, and Application
9.14.4 Philips AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.14.5 Philips Recent Developments
9.15 Siemens
9.15.1 Siemens Company Information, Head Office, Market Area, and Industry Position
9.15.2 Siemens Company Profile and Main Business
9.15.3 Siemens AI Chronic Disease Management Models, Specifications, and Application
9.15.4 Siemens AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.15.5 Siemens Recent Developments
9.16 Assure Tech
9.16.1 Assure Tech Company Information, Head Office, Market Area, and Industry Position
9.16.2 Assure Tech Company Profile and Main Business
9.16.3 Assure Tech AI Chronic Disease Management Models, Specifications, and Application
9.16.4 Assure Tech AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.16.5 Assure Tech Recent Developments
9.17 Alibaba Group
9.17.1 Alibaba Group Company Information, Head Office, Market Area, and Industry Position
9.17.2 Alibaba Group Company Profile and Main Business
9.17.3 Alibaba Group AI Chronic Disease Management Models, Specifications, and Application
9.17.4 Alibaba Group AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.17.5 Alibaba Group Recent Developments
9.18 Ping An Insurance
9.18.1 Ping An Insurance Company Information, Head Office, Market Area, and Industry Position
9.18.2 Ping An Insurance Company Profile and Main Business
9.18.3 Ping An Insurance AI Chronic Disease Management Models, Specifications, and Application
9.18.4 Ping An Insurance AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.18.5 Ping An Insurance Recent Developments
9.19 Fangzhou Inc
9.19.1 Fangzhou Inc Company Information, Head Office, Market Area, and Industry Position
9.19.2 Fangzhou Inc Company Profile and Main Business
9.19.3 Fangzhou Inc AI Chronic Disease Management Models, Specifications, and Application
9.19.4 Fangzhou Inc AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.19.5 Fangzhou Inc Recent Developments
9.20 Jianhai Technology
9.20.1 Jianhai Technology Company Information, Head Office, Market Area, and Industry Position
9.20.2 Jianhai Technology Company Profile and Main Business
9.20.3 Jianhai Technology AI Chronic Disease Management Models, Specifications, and Application
9.20.4 Jianhai Technology AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.20.5 Jianhai Technology Recent Developments
9.21 Lepu Medical
9.21.1 Lepu Medical Company Information, Head Office, Market Area, and Industry Position
9.21.2 Lepu Medical Company Profile and Main Business
9.21.3 Lepu Medical AI Chronic Disease Management Models, Specifications, and Application
9.21.4 Lepu Medical AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.21.5 Lepu Medical Recent Developments
9.22 Sinocare
9.22.1 Sinocare Company Information, Head Office, Market Area, and Industry Position
9.22.2 Sinocare Company Profile and Main Business
9.22.3 Sinocare AI Chronic Disease Management Models, Specifications, and Application
9.22.4 Sinocare AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.22.5 Sinocare Recent Developments
9.23 Xunfei Healthcare
9.23.1 Xunfei Healthcare Company Information, Head Office, Market Area, and Industry Position
9.23.2 Xunfei Healthcare Company Profile and Main Business
9.23.3 Xunfei Healthcare AI Chronic Disease Management Models, Specifications, and Application
9.23.4 Xunfei Healthcare AI Chronic Disease Management Revenue and Gross Margin, 2020-2025
9.23.5 Xunfei Healthcare Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

According to YH Research, the global market for AI Chronic Disease Management should grow from US$ 1648 million in 2024 to US$ 5075 million by 2031, with a CAGR of 17.3% for the period of 2025-2031.

AI chronic disease management uses artificial intelligence (AI) to digitally and intelligently manage the entire lifecycle of chronic diseases (such as diabetes, hypertension, coronary heart disease, and chronic obstructive pulmonary disease). Its core approach involves real-time collection and analysis of patients' electronic medical records, test data, wearable device monitoring information, and lifestyle data through big data, machine learning, natural language processing, knowledge graphs, and intelligent algorithms. This enables disease risk prediction, personalized intervention, medication guidance, rehabilitation tracking, and remote follow-up. Compared to traditional manual management, AI chronic disease management can significantly improve diagnosis and treatment efficiency, reduce physician burden, lower medical costs, and help patients develop long-term healthy behaviors. It has broad application value in smart hospitals, internet medical platforms, medical insurance cost control, and family health management, and is a key direction for the future development of digital healthcare and precision medicine.

AI Chronic Disease Management

According to YH Research, the global market for AI Chronic Disease Management should grow from US$ 1648 million in 2024 to US$ 5075 million by 2031, with a CAGR of 17.3% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China AI Chronic Disease Management market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031. The United States AI Chronic Disease Management market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

By segment, Home grew percent to account for percent of the total market sales, and Commercial grew percent.

This report studies and analyses global AI Chronic Disease Management status and future trends, to help determine the AI Chronic Disease Management market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for AI Chronic Disease Management, and provides market size (US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global AI Chronic Disease Management market size, history data 2020-2025, and forecast data 2026 -2031, (US$ million)
(2) Global AI Chronic Disease Management by company, revenue, market share and industry ranking 2020-2025, (US$ million)
(3) China AI Chronic Disease Management by company, revenue, market share and industry ranking 2020-2025, (US$ million)
(4) Global AI Chronic Disease Management key consuming regions, consumption value and demand structure
(5) AI Chronic Disease Management industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Teladoc Health
    S3 Connected Health
    Cognizant
    Omada Health
    WellDoc
    Epic Systems
    Pathmate
    EveryDose
    Aptar Digital Health
    VITech
    Virta Health
    Glooko
    Dexcom
    Philips
    Siemens
    Assure Tech
    Alibaba Group
    Ping An Insurance
    Fangzhou Inc
    Jianhai Technology
    Lepu Medical
    Sinocare
    Xunfei Healthcare

Market segment by Type, covers
    Mobile Applications
    Wearable Hardware
    Cloud Platform
    Others

Market segment by Application, can be divided into
    Home
    Commercial
    Medical
    Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe AI Chronic Disease Management product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global AI Chronic Disease Management market share and ranking of major manufacturers, revenue, 2020-2025
Chapter 3: China AI Chronic Disease Management market share and ranking of major manufacturers, revenue, 2020-2025
Chapter 4: AI Chronic Disease Management industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2020-2031
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2020-2031
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions